Form 4: Cartesian Therapeutics Officer Exercises Stock Options
SEC Form 4 Filing
Emily English, Chief Operations Officer of Cartesian Therapeutics, exercised stock options on April 15, 2025, acquiring 7,500 shares of common stock.
Summary
- On April 15, 2025, Emily English, the Chief Operations Officer of Cartesian Therapeutics, exercised stock options to acquire 7,500 shares of common stock at a price of $3.3 per share.
- Following this transaction, Ms. English directly owns 47,726 shares of common stock.
- The exercised stock options were fully vested and exercisable.
- These options originated from a conversion of Old Cartesian common stock options following the merger on November 13, 2023.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the actions of company executives. It's common for officers to exercise stock options as part of their compensation packages.
Key Dates
| Date | Description |
|---|---|
| November 13, 2023 | Cartesian Therapeutics acquired Old Cartesian in a merger. |
| April 15, 2025 | Emily English exercised stock options. |
| April 16, 2025 | Date of Form 4 signature. |
| April 25, 2031 | Expiration date of stock options. |
Keywords
stock options, Form 4, Cartesian Therapeutics, Emily English, insider trading, RNAC, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.